FibroGen : Eluminex Biosciences Exclusively Licenses FibroGen s Biosynthetic Cornea Technology and Recombinant Collagen III Platform (Form 8-K) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Eluminex Biosciences Exclusively Licenses FibroGen s Biosynthetic Cornea Technology and Recombinant Collagen III Platform forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Operator
Welcome to the Lineage Cell Therapeutics first-quarter 2021 conference call. [Operator instructions] An audio webcast of this call is available on the Investors section of Lineage s website at www.lineagecell.com. This call is subject to copyright and is the property of Lineage and recordings, reproduction, or transmission of this call without the expressed written consent of Lineage are strictly prohibited. As a reminder, today s call is being recorded.
I would now like to introduce your host for today s conference, Ioana Hone, director of investor relations at Lineage. Ms. Hone, please go ahead.
Ioana Hone
Director of Investor Relations
AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.